Vistagen Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.18

+0.00 (+0.34%)

Analyst Consensus

Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 5 63%

Sell 3 38%

Price Target

Analyst Price Target +27,475.3% upside

Low Target $36.23

Average Target $49.47

High Target $53.77

Current Price $0.18

Current
$0.18

Target
$49.47

$36.23 $49.47 avg $53.77

Scenario Analysis

Bear Case

$36.23

20,095.1%

Low target

Base Case

$49.47

+27,475.3%

Avg target

Bull Case

$53.77

+29,872.1%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$5.14

-96.5% from high

52-Week Low

$0.17

+8.7% from low

Target vs 52W High

$49.47

+862.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%